 |
White House Orders 171
Million Doses of “New”
Boosters for the Pro-Vaxxers
Still Alive as COVID-19
Vaccine Market Dwindles
by Brian Shilhavy
Editor, Health Impact News
The pharma-funded corporate media announced yesterday that the White House has ordered 171 million “new” doses of COVID-19 vaccine booster shots that should be available for the COVID-19 pro-vaccine members of the American public soon who are still alive after receiving previous COVID-19 shots.
Newly updated COVID-19 boosters tailored to target a dominant strain of the virus will be available in the next three weeks or so, assuming the Food and Drug Administration and Centers for Disease Control and Prevention work through their processes for authorization as expected, White House COVID coordinator Dr. Ashish Jha’s predicted on Tuesday.
In late June, the FDA directed Moderna and Pfizer to make vaccines for the upcoming winter that targeted the more contagious BA.5 omicron subvariant, along with the original COVID strain. That work has been underway and the next step is for the FDA and CDC to review data from the companies, once they’ve received it.
The rollout was expected sometime in September, but Jha’s estimate on Tuesday was the most specific to date.
“We’re going to know more about this in the upcoming weeks and these vaccines will become available by early to mid-September,” Jha said at an event hosted by the U.S. Chamber of Commerce Foundation, again including the caveat that FDA and CDC need to act before anything can be official.
“But the big picture, bottom line, is these are substantial upgrades in our vaccines,” Jha said. “And those vaccines are coming very, very soon.”
So far the U.S. has contracted for 105 million doses of the newly-updated boosters from Pfizer and 66 million doses from Moderna, the two leading COVID vaccine manufacturers for the country. Both contracts with Pfizer and Moderna include an option for hundreds of millions of more doses down the line, should the U.S. secure the money.
Between Pfizer and Moderna, if both companies were able to complete their orders, the U.S. would have about 171 million doses of the new shots. But more than 260 million Americans have had at least one vaccine dose already and would theoretically consider getting a booster. (Source.)
The problem is that those who want COVID-19 vaccines are a dwindling market, partly because millions of people in the U.S. have now been crippled or have died after taking the vaccines for the past 20 months, according to the CDC and FDA’s own statistics in the Vaccine Adverse Events Recording System (VAERS).
 |
There are more deaths and injuries following emergency-use authorized experimental COVID-19 vaccines in 20 months than have been recorded in VAERS for the previous 30 years following all FDA-approved vaccines.
That’s not a very good repeat business model, when so many of your patients are dying and becoming crippled. And it is estimated that only 1% of all vaccine injuries and deaths are reported to VAERS, which would put the number of Americans injured by a COVID-19 vaccine at around 138 million, with around 3 million deaths.
The ABC report acknowledged that this is a dwindling market:
… demand for boosters has dropped with each campaign for people to get another shot. About 108 million people have received their first booster shot, for example.
According to the CDC’s “COVID Data Tracker,” 261,981,618 people have received at least one dose of a COVID-19 vaccine, 107,872,738 people have received a first booster, and only 35,200,364 have received a second booster.
This is a diminishing market, and I am quite sure that the majority of the 171 million “new” doses will probably never be used.
Millions of doses of previous COVID vaccines have already been discarded due to lack of demand and exceeding their expiration dates, but that has not stopped Pfizer and Moderna from recording record profits, even when their vaccines don’t sell and are thrown away.
While new polls show flatlining concern about the pandemic among Americans, Moderna’s COVID-19 vaccine business continues quietly churning in the background. But amid a recent decline in vaccine demand, the company has written off a sizable chunk of inventory.
In its second-quarter results announcement, Moderna said it wrote off $499 million in inventories “related to COVID-19 products that have exceeded or are expected to exceed their approved shelf-lives prior to being used.”
In addition, the company took a $184 million charge because of changes in prior purchase commitments, and it recorded an expense of $131 million for “unutilized external manufacturing capacity.” (Source.)
Reducing the Population of the Earth is the Goal
So why would Big Pharma continue with a product that is killing and injuring so many people, and significantly reducing their market among the pro-vaxxers?
The answer, which should be obvious to all by now, at least for those who have refused the COVID-19 “vaccines” and can still think for themselves, is that this is part of a global plan to “save the Earth” from climate change.
Along with reducing the world’s population is a plan that is currently in place, and can especially be seen in Holland right now, to dramatically reduce the world food production as well.
Bill Gates is the Billionaire Globalist who has been pushing this agenda for decades now, and a report published in ZeroHedge News today also identifies Bill Gates as the primary influence behind the “Inflation Reduction Act” that was just recently put into law.
Read more
source
